Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China
Pneumocystis pneumonia (PCP) is an opportunistic and potentially life-threatening infection of AIDS patients caused by the fungus Pneumocystis jirovecii (P. jirovecii). Trimethoprim-sulfamethoxazole (TMP-SMX) is the most commonly used drug combination in the treatment and prophylaxis of PCP. However...
Main Authors: | Mingli Zhu, Ning Ye, Jiru Xu, Rubén Morilla |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2020-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7482917/?tool=EBI |
Similar Items
-
Clinical characteristics and prevalence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii-infected AIDS patients from low endemic areas of China.
by: Mingli Zhu, et al.
Published: (2020-01-01) -
Sulfa Use, Dihydropteroate Synthase Mutations, and Pneumocystis jirovecii Pneumonia
by: Cheryl R. Stein, et al.
Published: (2004-10-01) -
Epidemiology and clinical relevanceof Pneumocystis jirovecii Frenkel, 1976 dihydropteroate synthase gene mutations*
by: Matos O., et al.
Published: (2010-09-01) -
Dihydropteroate Synthase Gene Mutations in Pneumocystis and Sulfa Resistance
by: Laurence Huang, et al.
Published: (2004-10-01) -
Low prevalence of Pneumocystis pneumonia (PCP) but high prevalence of pneumocystis dihydropteroate synthase (dhps) gene mutations in HIV-infected persons in Uganda.
by: Steve M Taylor, et al.
Published: (2012-01-01)